208 related articles for article (PubMed ID: 24552415)
1. Periungual and subungual pyogenic granuloma following anti-TNF-α therapy: is it the first case?
Patruno C; Balato N; Cirillo T; Napolitano M; Ayala F
Dermatol Ther; 2013; 26(6):493-5. PubMed ID: 24552415
[TBL] [Abstract][Full Text] [Related]
2. [Therapy of psoriasis vulgaris and psoriatic arthritis with etanercept].
Mrowietz U; Barth J; Boehncke WH; Rosenbach T; Wozel G
J Dtsch Dermatol Ges; 2005 Jun; 3(6):470-2. PubMed ID: 15892851
[No Abstract] [Full Text] [Related]
3. Paclitaxel-associated subungual pyogenic granuloma: report in a patient with breast cancer receiving paclitaxel and review of drug-induced pyogenic granulomas adjacent to and beneath the nail.
Paul LJ; Cohen PR
J Drugs Dermatol; 2012 Feb; 11(2):262-8. PubMed ID: 22270214
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of subcutaneous anti-tumor necrosis factor-alpha agents, etanercept and adalimumab, in elderly patients affected by psoriasis and psoriatic arthritis: an observational long-term study.
Esposito M; Giunta A; Mazzotta A; Zangrilli A; Babino G; Bavetta M; Perricone R; Chimenti S; Chimenti MS
Dermatology; 2012; 225(4):312-9. PubMed ID: 23295383
[TBL] [Abstract][Full Text] [Related]
5. Exacerbation of psoriatic skin lesions in patients with psoriatic arthritis receiving anti-tumour necrosis factor-alpha therapy: description of 3 cases and review of the literature.
Mourão AF; Rustin M; Isenberg D
Clin Exp Rheumatol; 2010; 28(3):408-10. PubMed ID: 20576227
[TBL] [Abstract][Full Text] [Related]
6. Infliximab to etanercept switch in patients with spondyloarthropathies and psoriatic arthritis: preliminary data.
Delaunay C; Farrenq V; Marini-Portugal A; Cohen JD; Chevalier X; Claudepierre P
J Rheumatol; 2005 Nov; 32(11):2183-5. PubMed ID: 16265699
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment with etanercept of von Zumbusch pustular psoriasis in a patient with human immunodeficiency virus.
Mikhail M; Weinberg JM; Smith BL
Arch Dermatol; 2008 Apr; 144(4):453-6. PubMed ID: 18427038
[No Abstract] [Full Text] [Related]
8. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
[TBL] [Abstract][Full Text] [Related]
9. Extracapillary glomerulonephritis during etanercept treatment for juvenile psoriatic arthritis.
Menè P; Franeta AJ; Conti G; Stoppacciaro A; Chimenz R; Fede A; Gallizzi R; Fede C
Clin Exp Rheumatol; 2010; 28(1):91-3. PubMed ID: 20346246
[TBL] [Abstract][Full Text] [Related]
10. Periungual pyogenic granulomas due to topical tazarotene for nail psoriasis.
Piraccini BM; Venturi M; Patrizi A
G Ital Dermatol Venereol; 2014 Jun; 149(3):363-6. PubMed ID: 24819765
[TBL] [Abstract][Full Text] [Related]
11. [Psoriasis and psoriatic rheumatism: effectiveness of etanercept for cutaneous and joint lesions].
Paul C; Solignac M
Ann Dermatol Venereol; 2010 Apr; 137(4 Suppl):13-5. PubMed ID: 20510165
[No Abstract] [Full Text] [Related]
12. Anti-TNF-alpha treatment: a possible promoter in endogenous uveitis? observational report on six patients: occurrence of uveitis following etanercept treatment.
Kakkassery V; Mergler S; Pleyer U
Curr Eye Res; 2010 Aug; 35(8):751-6. PubMed ID: 20673052
[TBL] [Abstract][Full Text] [Related]
13. Follow-up of psoriatic arthritis mutilans patients treated with anti-TNF-alpha therapy.
Pomerantz RG; Mody E; Husni ME; Qureshi AA
J Drugs Dermatol; 2009 Apr; 8(4):406-12. PubMed ID: 19363860
[TBL] [Abstract][Full Text] [Related]
14. [Adverse events during biological therapy -- focusing on dermatological side-effects].
Nagy G; Lukács K; Sziray A; Fazekas K; Florián A; Tamási L; Károlyi Z
Orv Hetil; 2011 Feb; 152(6):212-20. PubMed ID: 21278026
[TBL] [Abstract][Full Text] [Related]
15. Etanercept for psoriasis: two case reports.
Fidalgo A; Baptista J; Rocha Páris F; Caldas Lopes L; Ferreira A
Int J Clin Pharmacol Res; 2005; 25(4):159-63. PubMed ID: 16402631
[TBL] [Abstract][Full Text] [Related]
16. Acute injection site reaction to intraarticular etanercept administration.
Arnold EL; Khanna D; Paulus H; Goodman MP
Arthritis Rheum; 2003 Jul; 48(7):2078-9. PubMed ID: 12847708
[No Abstract] [Full Text] [Related]
17. [Active WHO class IV lupus nephritis in a patient treated with etanercept for a psoriasic arthritis].
Sacquépée M; Rouleau V; Cantin JF; Quirin N; Doussy Y; Valéry JC; Picu C; Tivollier JM
Nephrol Ther; 2010 Nov; 6(6):537-40. PubMed ID: 20599469
[TBL] [Abstract][Full Text] [Related]
18. Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors.
Deng A; Harvey V; Sina B; Strobel D; Badros A; Junkins-Hopkins JM; Samuels A; Oghilikhan M; Gaspari A
Arch Dermatol; 2006 Feb; 142(2):198-202. PubMed ID: 16490847
[TBL] [Abstract][Full Text] [Related]
19. Etanercept (Enbrel) -- an update.
Goffe B
Skin Therapy Lett; 2004 Dec-2005 Jan; 9(10):1-4, 9. PubMed ID: 15657632
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-alpha inhibition and VATER association: a causal relationship.
Carter JD; Valeriano J; Vasey FB
J Rheumatol; 2006 May; 33(5):1014-7. PubMed ID: 16652431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
